Tb Alternative Assets Ltd. Bio N Tech Se Transaction History
Tb Alternative Assets Ltd.
- $539 Million
- Q2 2025
A detailed history of Tb Alternative Assets Ltd. transactions in Bio N Tech Se stock. As of the latest transaction made, Tb Alternative Assets Ltd. holds 28,917 shares of BNTX stock, worth $3.21 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
28,917
Previous 38,996
25.85%
Holding current value
$3.21 Million
Previous $3.55 Million
13.3%
% of portfolio
0.57%
Previous 0.85%
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
335Shares Held
39.9MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$906 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$473 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$449 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$210 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$201 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...